Apellis Pharmaceuticals I... (APLS)
24.28
0.00 (0.00%)
At close: Mar 28, 2025, 3:59 PM
24.75
1.94%
After-hours: Mar 28, 2025, 05:09 PM EDT
Apellis Pharmaceuticals Revenue
Apellis Pharmaceuticals reported an annual revenue of $396.59M, reflecting a 425.83% growth. For the quarter ending September 30, 2024, Apellis Pharmaceuticals generated $196.83M in revenue.
Revenue (ttm)
$396.59M
Revenue Growth
425.83%
Price / Sales Ratio
17.91
Revenue / Employee
$564.94K
Employees
702
Market Cap
3.05B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | % Change |
|---|---|---|
| Dec 31, 2023 | 396.59M | +425.83% |
| Dec 31, 2022 | 75.42M | +13.31% |
| Dec 31, 2021 | 66.56M | -73.44% |
| Dec 31, 2020 | 250.65M | n/a |